NCT01487031
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +24 more
- Locations
-
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Clinical trial condition
Paraproteinemias
Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.
3,004 public trials
571 recruiting studies
Paraproteinemias trial results
NCT00480363
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Hospital germans Trias i Pujol Badalona, Spain
- Hospital Clínic i Provincial de Barcelona Barcelona, Spain
- Hospital de la Santa Creu i Sant Pau Barcelona, Spain
- Hospital del SAS de Jerez de la Frontera Jerez de la Frontera, Spain
NCT00507442
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Rocky Mountain Cancer Center Denver, Colorado, United States
- Mayo Clinic Rochester, Minnesota, United States
Completed
Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma
NCT00723359
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Emory University Winship Cancer Institute Atlanta, Georgia, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- Mount Sinai Medical Center New York, United States
NCT00003493
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States
NCT00003554
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States
Completed
Quality of Life of Non-transplant Candidate Multiple Myeloma Patients Treated With Early Bortezomib
NCT01060202
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
NCT01402687
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Digestive System Diseases, +24 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00006013
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- University of Chicago Cancer Research Center Chicago, Illinois, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
Completed
Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease
NCT00871702
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +19 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States